Trial · NCT00004124
Adverse events126
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 126
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Allergic rhinitis | Respiratory, thoracic and mediastinal disorders | Arm I: Bicalutamide + Goserelin | 6 | 469 | |
| other | Allergic rhinitis | Respiratory, thoracic and mediastinal disorders | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 23 | 460 | |
| other | Anemia | Blood and lymphatic system disorders | Arm I: Bicalutamide + Goserelin | 71 | 469 | |
| other | Anemia | Blood and lymphatic system disorders | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 152 | 460 | |
| other | Leukopenia | Investigations | Arm I: Bicalutamide + Goserelin | 20 | 469 | |
| other | Leukopenia | Investigations | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 319 | 460 | |
| other | Lymphopenia | Investigations | Arm I: Bicalutamide + Goserelin | 8 | 469 | |
| other | Lymphopenia | Investigations | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 51 | 460 | |
| other | Neutropenia/granulocytopenia | Investigations | Arm I: Bicalutamide + Goserelin | 13 | 469 | |
| other | Neutropenia/granulocytopenia | Investigations | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 240 | 460 | |
| other | Thrombocytopenia | Investigations | Arm I: Bicalutamide + Goserelin | 7 | 469 | |
| other | Thrombocytopenia | Investigations | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 36 | 460 | |
| other | Edema | Cardiac disorders | Arm I: Bicalutamide + Goserelin | 50 | 469 | |
| other | Edema | Cardiac disorders | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 65 | 460 | |
| other | Hypertension | Cardiac disorders | Arm I: Bicalutamide + Goserelin | 58 | 469 | |
| other | Hypertension | Cardiac disorders | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 51 | 460 | |
| other | Fatigue/malaise/lethargy | General disorders | Arm I: Bicalutamide + Goserelin | 268 | 469 | |
| other | Fatigue/malaise/lethargy | General disorders | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 365 | 460 | |
| other | Rigors/chills | General disorders | Arm I: Bicalutamide + Goserelin | 9 | 469 | |
| other | Rigors/chills | General disorders | Arm II: Mitoxantrone + Prednisone + Bivalutamid + Goserelin | 24 | 460 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00004124/events